WHAT IS IT?
A next-generation triple hormone receptor agonist targeting GLP-1, GIP, and Glucagon receptors.
WHAT DOES IT DO?
Induces unprecedented fat loss (up to 24% of body weight in trials) while significantly improving metabolic flexibility and hepatic lipid clearance.
HOW DO I USE IT?
Subcutaneous injection administered once weekly, titrating up slowly from 1mg to a maximum of 12mg based on tolerability.
DEPLOYED BY OPERATORSHEALTHTRENDS SCORE™
NO VERIFIED OPERATORS FOUND DEPLOYING THIS PROTOCOL.